Metabolix, Inc. is an innovation-driven specialty materials company focused on delivering high-performance biopolymer solutions to customers in the plastics industry. Metabolix’s Mirel® biopolymer resins, which are derived from renewable resources, are a family of biobased performance additives based on PHA (polyhydroxyalkanoates). Metabolix's proprietary biotechnology platform enables the creation of specialty biopolymers for use in a broad range of applications such as construction and packaging materials, as well as industrial, consumer and personal care products.
Whether you are a long-time shareholder in Metabolix or just beginning to consider an investment in our company, we are committed to providing you with useful information and convenient tools you need to make informed decisions about your investment.
Investors should note that we announce material information to our investors using our website, SEC filings, press releases, public conference calls and webcasts. We use these channels, as well as social media, to communicate with our shareholders and the public about our company, our products and other matters. It is possible that the information we post on social media could be deemed to be material information. Therefore, we encourage investors, the media, and others interested in our company to review the information we post on the social media channels listed at the top of our website
View all » Recent Releases
View all »Events & Presentations
View all »Recent SEC Filings
|424B3||prospectus filed pursuant to rule 424||Jun 8, 2016|
|POS AM||post-effective amendment||May 31, 2016|
|8-K||current report||May 19, 2016|
|10-Q||quarterly report||May 16, 2016|
|DEF 14A||definitive proxy statement||Apr 19, 2016|
|4||van, walsem johan||Apr 5, 2016|